AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disordersVincenzo Salpietro, Alison M. Muir, Christine L. Dixon et al.|Nature Communications|2019Cited by 249
De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical PhenotypeVandana Shashi, Jennifer E. Posey, Loren D.M. Peña et al.|The American Journal of Human Genetics|2016Cited by 87
De novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic DecompensationDongxue Mao, Hugo J. Bellen, Jim Bale et al.|The American Journal of Human Genetics|2020Cited by 69
Looking beyond the exome: a phenotype-first approach to molecular diagnostic resolution in rare and undiagnosed diseasesLoren D.M. Peña, Lorraine Potocki, Yong‐Hui Jiang et al.|Genetics in Medicine|2017Cited by 52
A second cohort of CHD3 patients expands the molecular mechanisms known to cause Snijders Blok-Campeau syndromeTheodore G. Drivas, Lot Snijders Blok, Holly Dubbs et al.|European Journal of Human Genetics|2020Cited by 52